Drawing for REPREFI

USPTO serial 79220436

REPREFI

Reviewed by CopyMark Law Group

Reg. 5603683Status 404
Filing date
Status date
Registration date
Nov 13, 2018
Examiner
LEE, YATSYE ISADORA
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with REPREFI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Maury M. Tepper, III

Maury M. Tepper, III Tepper & Eyster, PLLC3724 Benson DriveRALEIGH, NC 27609UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005antifungal preparations; antivirals; cardiovascular pharmaceuticals; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthmaSECTION 70 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 5, 2022DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Feb 5, 2022DETHDEATH OF INTERNATIONAL REGISTRATION—
Mar 15, 2019FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 26, 2019FICSFINAL DISPOSITION NOTICE SENT TO IB—
Feb 26, 2019FIMPFINAL DISPOSITION PROCESSED—
Feb 13, 2019FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Nov 13, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 28, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 28, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 24, 2018GPNXNOTIFICATION PROCESSED BY IB—
Aug 8, 2018OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 8, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 8, 2018OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jul 18, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 13, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 13, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 13, 2018ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Feb 3, 2018GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Feb 3, 2018GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 3, 2018CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 5, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 4, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 4, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 23, 2017RFNPREFUSAL PROCESSED BY IB—
Dec 11, 2017ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 11, 2017REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 4, 2017RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 4, 2017RFRRREFUSAL PROCESSED BY MPU—
Nov 23, 2017RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 22, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 21, 2017MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 20, 2017DOCKASSIGNED TO EXAMINER—
Nov 16, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 15, 2017LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Nov 9, 2017REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance